CIK 0001570562 · Accelerated filer
Evolus, Inc.
Sign in to watch- Ticker
- EOLS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 461385614
- Phone
- (949) 284-4555
- Business address
- 520 NEWPORT CENTER DRIVE, SUITE 1200, NEWPORT BEACH, CA, 92660
- Former names
- Evolus, Inc.
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Open-market sale 10% owner sold 2,187,511 shares at $8.50 ($18,593,844)
- 4 Open-market sale 10% owner sold 37,043 shares at $11.04 ($408,955)
- SC 13G/A Stake Amended Statement of Ownership
- 4 Grant or award Director acquired 8,293 shares (grant or award)
- 4 Grant or award Director acquired 8,293 shares (grant or award)
- 4 Grant or award Director acquired 8,293 shares (grant or award)
- 4 Grant or award Director acquired 8,293 shares (grant or award)
- 4 Grant or award Director acquired 8,293 shares (grant or award)
- 4 Grant or award Director acquired 8,293 shares (grant or award)
- 4 Grant or award Director acquired 8,293 shares (grant or award)
- 4 Grant or award See Remarks acquired 97,642 shares (grant or award)
- 4 Grant or award See Remarks acquired 187,927 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 62,642 shares (grant or award)
- 8-K Event Results of operations
- 8-K Event Material agreement
- 8-K Event Material agreement · New debt or obligation · Regulation FD disclosure
- 10-Q Report Quarterly Report
Page 12 of 28 · 558 filings